A Structural Imbalance in Africa’s Pharma Logistics
Africa’s pharmaceutical logistics sector is facing a deep structural imbalance, with limited airfreight capacity constraining both vaccine access and economic development across Sub-Saharan Africa.
A joint initiative by Pharma.Aero and TIACA reveals that the region accounts for just 2% of global air cargo capacity, despite being home to over 1.2 billion people.
This imbalance highlights a critical gap between healthcare demand and logistics infrastructure—one that continues to limit access to life-saving medicines while slowing trade efficiency.
Misaligned Trade Flows Undermine Efficiency
One of the most pressing challenges is the disconnect between inbound and outbound cargo flows:
- Vaccines and medicines are shipped into Africa
- Perishable agricultural goods are exported out of Africa
However, these flows are rarely synchronized.
According to Pharma.Aero Secretary General Frank Van Gelder, the lack of coordination between these sectors leads to inefficient capacity utilization and higher transport costs.
“Outbound pharma flows and inbound perishables rarely align… capacity planning is not optimised.”
This inefficiency creates bottlenecks that disproportionately affect time- and temperature-sensitive shipments, particularly vaccines.
Weak Intra-African Connectivity Increases Risk
Limited intra-African air connectivity further compounds the problem.
In some cases, it is faster to route shipments via hubs outside the continent—such as the Abu Dhabi—rather than transport goods directly between African countries like Kenya and Senegal.
This fragmented routing system:
- Increases transit times
- Raises costs
- Heightens risks for cold chain failures
For pharmaceuticals, where temperature control determines product viability, these inefficiencies can be life-threatening.
Agriculture and Health: A Missed Synergy
The imbalance is particularly striking given Africa’s economic structure:
- 40% of GDP in Sub-Saharan Africa depends on fresh produce
- 70% of the workforce is engaged in agriculture
- Yet 25% of global vaccine demand is concentrated in Africa
Despite strong agricultural exports, this economic activity has not translated into improved healthcare access.
Better alignment between pharma imports and agri-exports could unlock:
- More efficient air cargo utilization
- Lower logistics costs
- Improved vaccine distribution
- Sustainability Challenges Go Beyond Emissions
Sustainability in Africa’s pharma logistics sector extends beyond carbon emissions and includes:
1. Packaging Waste
Cold chain packaging must maintain product integrity but often becomes waste in rural areas. There is growing pressure on manufacturers to develop:
- Recyclable materials
- Reusable packaging solutions suited to African conditions
- 2. Falsified Medicines Crisis
The scale of counterfeit drugs in Africa is alarming:
- 1 in 5 medicines in circulation is falsified
- This contributes to approximately 700,000 deaths annually
Improving traceability and supply chain visibility is essential to combating this crisis.
3. Last-Mile Accessibility
Reaching remote communities remains a major barrier. Without reliable last-mile delivery systems:
- Vaccines fail to reach vulnerable populations
- Supply chain inefficiencies persist
- Regulatory Fragmentation Slows Progress
Africa’s regulatory environment is highly fragmented, with each country operating its own framework.
This creates:
Complex compliance requirements
Delays in cross-border shipments
Increased operational costs
Stronger collaboration between:
- Governments
- Regulators
- Pharmaceutical companies
- NGOs
is essential to streamline processes and improve logistics efficiency.
Building a More Resilient Pharma Supply Chain
The joint project by Pharma.Aero and TIACA emphasizes the need for a coordinated, system-wide approach to transform Africa’s pharma logistics landscape.
Key priorities include:
- Expanding airfreight capacity into Africa
- Strengthening intra-African transport corridors
- Aligning inbound and outbound cargo flows
- Investing in cold chain and last-mile infrastructure
- Enhancing traceability to combat counterfeit medicines
- The Bigger Picture: Health and Economic Growth
Improving pharma logistics is not just a healthcare issue—it is an economic imperative.
Efficient supply chains can:
- Boost agricultural exports
- Improve public health outcomes
- Reduce poverty
- Strengthen long-term resilience
As Van Gelder notes, aligning economic and health priorities could unlock significant untapped potential, positioning Africa as a key player in global air cargo and pharmaceutical logistics.
Conclusion
Africa’s pharma logistics sector stands at a crossroads. Without urgent investment and coordination, the current airfreight capacity gap will continue to limit both healthcare access and economic growth.
However, with the right reforms—focused on connectivity, sustainability, and collaboration—the continent has the potential to build a resilient, efficient, and inclusive pharmaceutical supply chain.